MedPath

TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

1181340004

Prescription Type

Uso Hospitalario

Authorization Date

Sep 9, 2020

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181340004
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

LANADELUMABActive
Quantity: 300 mg
Name: LANADELUMAB

ATC CLASSIFICATION (3)

B06A
B06AC
B06AC05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.